Trade Summary

1 month ago, ORBIMED ADVISORS LLC, serving as Dir at Q32 Bio Inc. (QTTB), purchased 1,875,000 shares at $8.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, ORBIMED ADVISORS LLC now holds 625,000 shares of QTTB.

The trade was executed on Thursday, May 28, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 2, 2026 (accepted Jun 1, 9:13 PM ET), 5 days after the trade was made.

Q32 Bio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.